Concepedia

Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study

Timothy D. Henry, A T Hirsch, Jo Anne Goldman, Y L Wang, Daniel Lips, William D. McMillan, Sue Duval, T A Biggs, Hong H. Keo

Gene Therapy · 2011 · 76 citations · 28 references

DOI

Concepts

References

28

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

The Lancet · 2005 · 1.9K citations

, , +12

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

John Dormandy, Robert B. Rutherford · PubMed · 2000 · 1.6K citations

, , +14

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Federico Bussolino, Maria Flavia Di Renzo, Marina Ziche et al. · The Journal of Cell Biology · 1992 · 1.4K citations · Full text

, , +14

ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)

Alan T. Hirsch, Ziv J. Haskal, Norman Hertzer et al. · Journal of the American College of Cardiology · 2006 · 1K citations

, , +17

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)

P M Rothwell, A J Coull, LE Silver et al. · The Lancet · 2005 · 962 citations

, , +14